## APD: Air Products and Chemicals, Inc - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -2.5% below STRENGTH zone (4.0-10.0%); PEG 6.69 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($231.17)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $42.62 Million Stock Holdings in Air Products and Chemicals, Inc. $APD**
- Source: MarketBeat | 20251213T100820 | Somewhat-Bullish | Relevance: 100%
- BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp reduced its stake in Air Products and Chemicals, Inc. (NYSE:APD) by 15.8% during the second quarter, now holding 151,107 shares valued at $42.62 million. Other institutional investors have also adjusted their positions in the company. Analysts currently rate Air Products and Chemicals with a "Moderate Buy" and an average target price of $302.67.

**2. Benjamin Edwards Inc. Has $24.91 Million Position in Air Products and Chemicals, Inc. $APD**
- Source: MarketBeat | 20251213T100736 | Somewhat-Bullish | Relevance: 100%
- Benjamin Edwards Inc. reduced its stake in Air Products and Chemicals, Inc. (NYSE:APD) by 7.5% in Q2, holding 88,313 shares valued at $24.91 million. Meanwhile, major institutional investors like Vanguard, State Street, Dodge & Cox, and JPMorgan significantly increased their positions, collectively holding 81.66% of the company's stock. Air Products reported mixed Q3 earnings, beating EPS consensus by $0.01 but showing a slight revenue decline year-over-year, and announced a quarterly dividend of $1.79 per share.

**3. (12/16/25) APD: An Industrial Gas Giant Offering Compelling Value**
- Source: www.moneyshow.com | 20251216T060740 | Somewhat-Bullish | Relevance: 100%
- Air Products & Chemicals Inc. (APD) saw its stock fall recently after announcing advanced talks with Yara International for two major industrial gas projects. Despite the dip, analyst John Buckingham views APD as a compelling value, maintaining a target price of $360 and highlighting the essential nature of industrial gases and the company's consistent dividend growth. The company's management expects these projects to not impact 2026 earnings guidance, and long-term capital expenditure is projected to decrease after major project completions.

**4. FORA Capital LLC Acquires New Stake in Air Products and Chemicals, Inc. $APD**
- Source: MarketBeat | 20251214T092628 | Neutral | Relevance: 100%
- FORA Capital LLC has acquired a new stake of 16,081 shares, valued at approximately $4.54 million, in Air Products and Chemicals, Inc. during the second quarter. Several other hedge funds have also adjusted their holdings in the company, with institutional investors now owning 81.66% of the stock. Air Products and Chemicals recently reported earnings that slightly beat analyst estimates and declared a quarterly dividend of $1.79 per share.

**5. Electron Capital Partners LLC Boosts Holdings in Air Products and Chemicals, Inc. $APD**
- Source: MarketBeat | 20251213T120737 | Somewhat-Bullish | Relevance: 100%
- Electron Capital Partners LLC significantly increased its stake in Air Products and Chemicals, Inc. (NYSE: APD) by 50.7% in Q2, making it their fourth-largest position. The firm now holds 469,679 shares valued at $132.48 million, accounting for 0.21% of the company's stock. Analysts currently rate APD as a "Moderate Buy" with a target price of $302.67, while the company reported Q3 EPS of $3.39 and declared a quarterly dividend of $1.79.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Citigroup | $245 | $300 | -18% |
| 2025-12-12 | UBS | $250 | $310 | -19% |
| 2025-12-11 | Argus Research | $265 | $317 | -16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Citigroup | down | Neutral |
| 2025-12-12 | UBS | down | Neutral |
| 2025-12-11 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 22 ($0.12M) |
| Sells | 3 ($0.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+1.2%)
- Blackrock Inc.: 7.9% (-0.1%)
- JPMORGAN CHASE & CO: 5.9% (+103.2%)
- State Farm Mutual Au: 5.3% (-1.3%)
- Capital Research Glo: 5.3% (+2.4%)

### Key Risks

1. Valuation stretched: PEG 6.7x requires aggressive growth execution.
2. Long-term trend broken: trading 11.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 6.69 signals overvaluation risk, limited margin of safety. Forward P/E 17.7x stretched relative to 7% growth. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $54.5B |
| Beta | 0.86 |
| 52W Range | $229.11 - $341.14 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.69 |
| Forward P/E | 17.7 |
| Current P/E | 19.0 |
| YoY Growth | 7.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -11.7% to -2.5% (+9.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.5pp (needs >4.0% for momentum thesis). MRS_5 turning positive (3.7%) - potential reversal signal. Underperforming sector by 5.5pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. MACD histogram bearish (-1.36), momentum weakening. RSI neutral at 44. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.53% (CS: 17) | Weak |
| RSI_14 | 43.9 | Neutral |
| MACD Histogram | -1.36 | Bearish |
| vs SMA20 | 0.973x | Below |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 0.886x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $245.01
- **Stop Loss:** $231.17 (5.6% risk)
- **Target:** $258.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $21,070.86
- **Portfolio %:** 21.07%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $3.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.38 | $3.39 | +0.2% |
| 2025Q2 | $2.99 | $3.09 | +3.2% |
| 2025Q1 | $2.83 | $2.69 | -4.9% |
| 2024Q4 | $2.84 | $2.86 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*